[Activity Report] The 11th Nikkei FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC) (October 23, 2024)
date : 11/7/2024
Tags: AMR
The AMR Consortium of the Asia Africa Medical Innovation Consortium, for which AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) serves as the secretariat, discussed innovation needed to address antimicrobial resistance (AMR) during the “Agenda4 Innovation” in the 11th NIKKEI FT Communicable Diseases Conference, organized by Nikkei Inc. and co-organized by THE FINANCIAL TIMES LTD.
During the meeting, AMR Consortium Co-Chair Kazuhiro Tateda (Professor, Department of Microbiology and Infectious Diseases, Toho University School of Medicine) shared his views on potential innovative solutions to combat AMR, including advancements in the field of drug discovery, vaccine development, bacteriophage therapy, diagnostic methods, approaches utilizing bacterial flora, as well as antibody drugs. He also reflected on the achievements of the AMR Consortium’s activities and policy development on AMR. The pressing need for a pull-type incentive system and the establishment of a drug discovery ecosystem that contributes to infection control measures were also mentioned during the discussion, and participants agreed on its importance and urgency.
[Overview]
- Date: Wednesday, October 23, 2024
- Program: Agenda4 Innovation

Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] AMR Policy Update #9: Stockholm Residents’ Awareness and Practices in Returning and Recycling Pharmaceuticals: Findings from Local Interviews (July 15, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
-
2026-07-24
[Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
-
2026-07-30
[Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)



